Internal Medicine, Gastroenterology · Hemet, CA
NPI
1295864395
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1003 E Florida Ave Ste 101, 1003 E Florida Ave Ste 101
Hemet, CA, 92543
Phone (951) 652-2252
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
524 services
Medicare patients, 2024
216
Average age 69
Drug cost, 2024
$116K
1,612 prescriptions
Company payments, 2025
$1,319
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tahir Qaseem was code 99214 (office e&m - established), 155 times for 105 patients. In total Tahir Qaseem billed 524 services in 11 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 155 | 105 | $99.66 | $15K |
| 43239 Upper GI Endoscopy | Facility | 113 | 107 | $112.69 | $13K |
| 45380 Lower GI Endoscopy - Other | Facility | 94 | 88 | $142.34 | $13K |
| 99204 Office E&M - New | Office | 89 | 89 | $122.52 | $11K |
| 43450 Digestive/Gastrointestinal | Facility | 39 | 38 | $33.28 | $1,298 |
| 45385 Colonoscopy - Lesion Removal | Facility | 17 | 15 | $207.26 | $3,523 |
By year: 2022 $62K for 585 services; 2023 $57K for 510 services; 2024 $60K for 524 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tahir Qaseem prescribed most often to Medicare patients was Famotidine, with 859 prescriptions and refills. In total Tahir Qaseem wrote 1,612 Medicare prescriptions that cost $116K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 859 | 2,219 | 386 | $11K |
| Pantoprazole Sodium Generic | 417 | 1,056 | 186 | $4,175 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 67 | 67 | 66 | $1,063 |
| Sucralfate Generic | 49 | 51 | 23 | $1,963 |
| Omeprazole Generic | 41 | 86 | 24 | $538 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 26 | 26 | 24 | $387 |
| Talicia Omeprazole/Amoxicill/Rifabutin | 26 | 26 | 26 | $20K |
| Dexlansoprazole Dr Dexlansoprazole | 14 | 30 | Under 11 | $5,345 |
| Clarithromycin Generic | 13 | 13 | 11 | $298 |
| Mesalamine Generic | 12 | 22 | Under 11 | $2,770 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 12 | 12 | 12 | $205 |
Brand drugs: 100 claims; generic drugs: 1,512 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tahir Qaseem $1,319 ($1,319 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $384.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $384 |
| Ardelyx, Inc. ARDX | 11 | $354 |
| Madrigal Pharmaceuticals MDGL | 6 | $263 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $72.58 |
| Echosens North America, Inc. | 1 | $49.82 |
| Janssen Biotech, Inc. JNJ | 2 | $43.8 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $35.73 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $24.84 |
| Gilead Sciences, Inc. GILD | 1 | $21.46 |
| QOL Medical, LLC | 1 | $21.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.